So haben sie auf Brustkrebs aufmerksam gemacht.

In Kocaeli, women walked dressed in pink throughout October to raise awareness about breast cancer and to educate citizens.

The Kocaeli Metropolitan Municipality organized various events throughout October to draw attention to the Breast Cancer Awareness Month from October 1-31. The events, carried out by the Women and Family Services Branch of the Department of Women and Family Services, aimed to inform the community and individuals about breast cancer and to raise awareness. As part of the breast cancer awareness week organized by the Kocaeli Metropolitan Municipality, walks were held in the districts of Izmit, Gölcük, Körfez, and Derince. Participants showed great interest in the events held at the Anne Şehir Merkezi Yasemin, Günebakan, Begonya, and Şehit Er Emre Kaan Arlı Sports Hall facilities. During the events, women highlighted the importance of early diagnosis in breast cancer by walking with banners that read “Kocaeli Anneleri Ekimde Pembe Giyer”, “Meme Kanseri Farkındalık Ayı”, “Kanserde Erken Tanı Hayat Kurtarır”, “Kendi Kendine Muayene Hayat Kurtarır”, “Kanserden Değil Geç Kalmaktan Kork” and “Farkındayım Korkmuyorum”.

The walk held in the districts of Izmit, Derince, and Körfez was also accompanied by the KETEM unit of the Provincial Health Directorate. In the program, KETEM officials informed participants about the definition of breast cancer, its symptoms, the importance of early diagnosis, the significance of regular check-ups for breast cancer, and self-examination. After the program, participants engaged in outdoor sports activities under the guidance of trainers from the Anne Şehir Healthy Living Program.

As part of the organized events, seminars were held at GEBZESEM for participants at the Anne Şehir Merkezi Gardenya, Gelincik, Manolya, Nilüfer, and Mimoza facilities by specialists in the field. The seminar provided information on the diagnosis and treatment methods of breast cancer, symptoms of breast cancer, and the importance of early diagnosis in breast cancer, and participants’ questions were answered.